Archive for the ‘bentham’ Category
Last year, we reported on an investigation by the University of Colorado Denver into the research of Rajendra Kadam, which recommended retracting 10 papers. The report also flagged eight additional papers co-authored by Kadam whose data could not be validated, raising “concerns as to the scientific validity and integrity” of the material. A few months later, we reported on some of the notices — four retractions and an EOC — that had begun to appear for Kadam’s manuscripts.
We’ve since discovered more notices, bringing his total to seven retractions and three EOCs.
Kadam was once a prominent member in the lab of Uday Kompella, and often referred to by colleagues as the “golden boy,” according to the institution’s report. In 2012, he won a graduate student symposium award from the American Association of Pharmaceutical Scientists.
A University of Colorado Denver spokesperson told Retraction Watch: Read the rest of this entry »
An engineering journal has retracted two papers for faked or rigged peer review, but authors of one of the papers are objecting to the retraction.
The first author of that paper told us he and his co-authors “absolutely disagree” with the retraction, and are prepared to use “legal means” to safeguard their “rights and interests.” He added:
…my paper was published by normal ways, I don’t know why the peer review process was compromised and what the journal found in its investigation.
The Open Automation and Control Systems Journal has published five items this calendar year — and all of those are retraction notices.
That’s what we’re sure about. Now to what we’re not clear on in this story, which is one of a growing number of cases we’ve seen in which so-called “predatory” publishers are starting to retract papers, perhaps because they hope the practice suggests they are rigorous. Four of the papers have been pulled for “compromised” peer review, some of which are due to the actions of an “external agent,” according to the journal. A co-author of one of these manuscripts, however, claims the paper has been pulled for using material from another researcher’s paper without acknowledgement but the journal has retracted it for issues with peer review.
The remaining paper has been pulled for plagiarizing from another published paper.
The retracted article is “Generation of Knock down Tools for Transcription Factor 7-like-2 (TCF7L2) and Evaluation of its Expression Pattern in Developing Chicken Optic Tectum,” published just last year in MicroRNA.
We’ll get right to the reason — the retraction note provides one short one:
Protein & Peptide Letters, a Bentham title, has retracted a paper for plagiarism, but it’s the unhelpful — bordering on insulting — notice that caught our eye.
The abstract for the notice, the rest of which sits behind a $63.10 (plus tax) pay wall on Ingenta Connect, reads:
As per Bentham Science’s policy, the following article has been retracted at the request of the Editor-in-Chief and its Authors published in `Protein & Peptide Letters“ due to their use of text obtained from another paper published in the Biochemical Journal.
Oh, my. Where to begin…
For $63 plus tax, you can have a single steak with a side order of fried potatoes and a wedge of crisp iceberg lettuce at the famed Peter Luger steakhouse in Brooklyn. Or you can get a peek at one measly retraction notice from Bentham Science Publishers (at least it’s BYOB).
To be fair, the publisher, based in the United Arab Emirates, does offer a free version of the notice on its own website. But Bentham uses the company Ingenta Connect as a go-between to collect fees — some of which reach $100 per article, according to a company employee — and as far as we can tell, no such gratis access is available through the middleman. Neither does Ingenta direct readers to the free version in its landing page for the notice.
The article in question, “Solubilization and Amorphization of Non Steroidal Anti-Inflammatory Drug with Low Molecular Weight Chitosan for a New Guar-Based Colon Delivery Formulation,” by Kadria A. Elkhodairy, Nahla S. Barakat and Fars K. Alanazi, appeared in the March 2011 issue of Letters in Drug Design & Discovery. The retraction notice reads: Read the rest of this entry »